The global Drugs for Pain Management market was valued at US$ 35360 million in 2023 and is anticipated to reach US$ 41890 million by 2030, witnessing a CAGR of 2.4% during the forecast period 2024-2030.

Drugs for Pain Management Market

Pain is complex, so there are many treatment options -- medications, therapies, and mind-body techniques.

This report is mainly about the drugs for pain management.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Drugs for Pain Management, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drugs for Pain Management.

Report Scope

The Drugs for Pain Management market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Drugs for Pain Management market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Drugs for Pain Management companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Drugs for Pain Management Market Report

Report Metric	Details
Report Name	Drugs for Pain Management Market
Accounted market size in 2023	US$ 35360 million
Forecasted market size in 2030	US$ 41890 million
CAGR	2.4%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Generic Opioid Branded Opioids NSAIDs Others
Segment by Application	Hospitals Drugstores Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	GSK, Pfizer, Grunenthal, Sanofi, Bayer, AstraZeneca, Eli Lilly, Endo, Merck, Yunnan Baiyao, Teikoku Seiyaku, Teva, J&J, Assertio Therapeutics, Allergan
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Drugs for Pain Management companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Drugs for Pain Management Market growing?

Ans: The Drugs for Pain Management Market witnessing a CAGR of 2.4% during the forecast period 2024-2030.

What is the Drugs for Pain Management Market size in 2030?

Ans: The Drugs for Pain Management Market size in 2030 will be US$ 41890 million.

Who are the main players in the Drugs for Pain Management Market report?

Ans: The main players in the Drugs for Pain Management Market are GSK, Pfizer, Grunenthal, Sanofi, Bayer, AstraZeneca, Eli Lilly, Endo, Merck, Yunnan Baiyao, Teikoku Seiyaku, Teva, J&J, Assertio Therapeutics, Allergan

What are the Application segmentation covered in the Drugs for Pain Management Market report?

Ans: The Applications covered in the Drugs for Pain Management Market report are Hospitals, Drugstores, Others

What are the Type segmentation covered in the Drugs for Pain Management Market report?

Ans: The Types covered in the Drugs for Pain Management Market report are Generic Opioid, Branded Opioids, NSAIDs, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Drugs for Pain Management Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Generic Opioid

1.2.3 Branded Opioids

1.2.4 NSAIDs

1.2.5 Others

1.3 Market by Application

1.3.1 Global Drugs for Pain Management Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Hospitals

1.3.3 Drugstores

1.3.4 Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Drugs for Pain Management Market Perspective (2019-2030)

2.2 Drugs for Pain Management Growth Trends by Region

2.2.1 Global Drugs for Pain Management Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Drugs for Pain Management Historic Market Size by Region (2019-2024)

2.2.3 Drugs for Pain Management Forecasted Market Size by Region (2025-2030)

2.3 Drugs for Pain Management Market Dynamics

2.3.1 Drugs for Pain Management Industry Trends

2.3.2 Drugs for Pain Management Market Drivers

2.3.3 Drugs for Pain Management Market Challenges

2.3.4 Drugs for Pain Management Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Drugs for Pain Management Players by Revenue

3.1.1 Global Top Drugs for Pain Management Players by Revenue (2019-2024)

3.1.2 Global Drugs for Pain Management Revenue Market Share by Players (2019-2024)

3.2 Global Drugs for Pain Management Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Drugs for Pain Management Revenue

3.4 Global Drugs for Pain Management Market Concentration Ratio

3.4.1 Global Drugs for Pain Management Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Drugs for Pain Management Revenue in 2023

3.5 Drugs for Pain Management Key Players Head office and Area Served

3.6 Key Players Drugs for Pain Management Product Solution and Service

3.7 Date of Enter into Drugs for Pain Management Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Drugs for Pain Management Breakdown Data by Type

4.1 Global Drugs for Pain Management Historic Market Size by Type (2019-2024)

4.2 Global Drugs for Pain Management Forecasted Market Size by Type (2025-2030)

5 Drugs for Pain Management Breakdown Data by Application

5.1 Global Drugs for Pain Management Historic Market Size by Application (2019-2024)

5.2 Global Drugs for Pain Management Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Drugs for Pain Management Market Size (2019-2030)

6.2 North America Drugs for Pain Management Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Drugs for Pain Management Market Size by Country (2019-2024)

6.4 North America Drugs for Pain Management Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Drugs for Pain Management Market Size (2019-2030)

7.2 Europe Drugs for Pain Management Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Drugs for Pain Management Market Size by Country (2019-2024)

7.4 Europe Drugs for Pain Management Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Drugs for Pain Management Market Size (2019-2030)

8.2 Asia-Pacific Drugs for Pain Management Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Drugs for Pain Management Market Size by Region (2019-2024)

8.4 Asia-Pacific Drugs for Pain Management Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Drugs for Pain Management Market Size (2019-2030)

9.2 Latin America Drugs for Pain Management Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Drugs for Pain Management Market Size by Country (2019-2024)

9.4 Latin America Drugs for Pain Management Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Drugs for Pain Management Market Size (2019-2030)

10.2 Middle East & Africa Drugs for Pain Management Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Drugs for Pain Management Market Size by Country (2019-2024)

10.4 Middle East & Africa Drugs for Pain Management Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 GSK

11.1.1 GSK Company Detail

11.1.2 GSK Business Overview

11.1.3 GSK Drugs for Pain Management Introduction

11.1.4 GSK Revenue in Drugs for Pain Management Business (2019-2024)

11.1.5 GSK Recent Development

11.2 Pfizer

11.2.1 Pfizer Company Detail

11.2.2 Pfizer Business Overview

11.2.3 Pfizer Drugs for Pain Management Introduction

11.2.4 Pfizer Revenue in Drugs for Pain Management Business (2019-2024)

11.2.5 Pfizer Recent Development

11.3 Grunenthal

11.3.1 Grunenthal Company Detail

11.3.2 Grunenthal Business Overview

11.3.3 Grunenthal Drugs for Pain Management Introduction

11.3.4 Grunenthal Revenue in Drugs for Pain Management Business (2019-2024)

11.3.5 Grunenthal Recent Development

11.4 Sanofi

11.4.1 Sanofi Company Detail

11.4.2 Sanofi Business Overview

11.4.3 Sanofi Drugs for Pain Management Introduction

11.4.4 Sanofi Revenue in Drugs for Pain Management Business (2019-2024)

11.4.5 Sanofi Recent Development

11.5 Bayer

11.5.1 Bayer Company Detail

11.5.2 Bayer Business Overview

11.5.3 Bayer Drugs for Pain Management Introduction

11.5.4 Bayer Revenue in Drugs for Pain Management Business (2019-2024)

11.5.5 Bayer Recent Development

11.6 AstraZeneca

11.6.1 AstraZeneca Company Detail

11.6.2 AstraZeneca Business Overview

11.6.3 AstraZeneca Drugs for Pain Management Introduction

11.6.4 AstraZeneca Revenue in Drugs for Pain Management Business (2019-2024)

11.6.5 AstraZeneca Recent Development

11.7 Eli Lilly

11.7.1 Eli Lilly Company Detail

11.7.2 Eli Lilly Business Overview

11.7.3 Eli Lilly Drugs for Pain Management Introduction

11.7.4 Eli Lilly Revenue in Drugs for Pain Management Business (2019-2024)

11.7.5 Eli Lilly Recent Development

11.8 Endo

11.8.1 Endo Company Detail

11.8.2 Endo Business Overview

11.8.3 Endo Drugs for Pain Management Introduction

11.8.4 Endo Revenue in Drugs for Pain Management Business (2019-2024)

11.8.5 Endo Recent Development

11.9 Merck

11.9.1 Merck Company Detail

11.9.2 Merck Business Overview

11.9.3 Merck Drugs for Pain Management Introduction

11.9.4 Merck Revenue in Drugs for Pain Management Business (2019-2024)

11.9.5 Merck Recent Development

11.10 Yunnan Baiyao

11.10.1 Yunnan Baiyao Company Detail

11.10.2 Yunnan Baiyao Business Overview

11.10.3 Yunnan Baiyao Drugs for Pain Management Introduction

11.10.4 Yunnan Baiyao Revenue in Drugs for Pain Management Business (2019-2024)

11.10.5 Yunnan Baiyao Recent Development

11.11 Teikoku Seiyaku

11.11.1 Teikoku Seiyaku Company Detail

11.11.2 Teikoku Seiyaku Business Overview

11.11.3 Teikoku Seiyaku Drugs for Pain Management Introduction

11.11.4 Teikoku Seiyaku Revenue in Drugs for Pain Management Business (2019-2024)

11.11.5 Teikoku Seiyaku Recent Development

11.12 Teva

11.12.1 Teva Company Detail

11.12.2 Teva Business Overview

11.12.3 Teva Drugs for Pain Management Introduction

11.12.4 Teva Revenue in Drugs for Pain Management Business (2019-2024)

11.12.5 Teva Recent Development

11.13 J&J

11.13.1 J&J Company Detail

11.13.2 J&J Business Overview

11.13.3 J&J Drugs for Pain Management Introduction

11.13.4 J&J Revenue in Drugs for Pain Management Business (2019-2024)

11.13.5 J&J Recent Development

11.14 Assertio Therapeutics

11.14.1 Assertio Therapeutics Company Detail

11.14.2 Assertio Therapeutics Business Overview

11.14.3 Assertio Therapeutics Drugs for Pain Management Introduction

11.14.4 Assertio Therapeutics Revenue in Drugs for Pain Management Business (2019-2024)

11.14.5 Assertio Therapeutics Recent Development

11.15 Allergan

11.15.1 Allergan Company Detail

11.15.2 Allergan Business Overview

11.15.3 Allergan Drugs for Pain Management Introduction

11.15.4 Allergan Revenue in Drugs for Pain Management Business (2019-2024)

11.15.5 Allergan Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Assertio Therapeutics

Allergan plc

List of Tables

Table 1. Global Drugs for Pain Management Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Generic Opioid

Table 3. Key Players of Branded Opioids

Table 4. Key Players of NSAIDs

Table 5. Key Players of Others

Table 6. Global Drugs for Pain Management Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global Drugs for Pain Management Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 8. Global Drugs for Pain Management Market Size by Region (2019-2024) & (US$ Million)

Table 9. Global Drugs for Pain Management Market Share by Region (2019-2024)

Table 10. Global Drugs for Pain Management Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 11. Global Drugs for Pain Management Market Share by Region (2025-2030)

Table 12. Drugs for Pain Management Market Trends

Table 13. Drugs for Pain Management Market Drivers

Table 14. Drugs for Pain Management Market Challenges

Table 15. Drugs for Pain Management Market Restraints

Table 16. Global Drugs for Pain Management Revenue by Players (2019-2024) & (US$ Million)

Table 17. Global Drugs for Pain Management Market Share by Players (2019-2024)

Table 18. Global Top Drugs for Pain Management Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drugs for Pain Management as of 2023)

Table 19. Ranking of Global Top Drugs for Pain Management Companies by Revenue (US$ Million) in 2023

Table 20. Global 5 Largest Players Market Share by Drugs for Pain Management Revenue (CR5 and HHI) & (2019-2024)

Table 21. Key Players Headquarters and Area Served

Table 22. Key Players Drugs for Pain Management Product Solution and Service

Table 23. Date of Enter into Drugs for Pain Management Market

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Drugs for Pain Management Market Size by Type (2019-2024) & (US$ Million)

Table 26. Global Drugs for Pain Management Revenue Market Share by Type (2019-2024)

Table 27. Global Drugs for Pain Management Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 28. Global Drugs for Pain Management Revenue Market Share by Type (2025-2030)

Table 29. Global Drugs for Pain Management Market Size by Application (2019-2024) & (US$ Million)

Table 30. Global Drugs for Pain Management Revenue Market Share by Application (2019-2024)

Table 31. Global Drugs for Pain Management Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 32. Global Drugs for Pain Management Revenue Market Share by Application (2025-2030)

Table 33. North America Drugs for Pain Management Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 34. North America Drugs for Pain Management Market Size by Country (2019-2024) & (US$ Million)

Table 35. North America Drugs for Pain Management Market Size by Country (2025-2030) & (US$ Million)

Table 36. Europe Drugs for Pain Management Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 37. Europe Drugs for Pain Management Market Size by Country (2019-2024) & (US$ Million)

Table 38. Europe Drugs for Pain Management Market Size by Country (2025-2030) & (US$ Million)

Table 39. Asia-Pacific Drugs for Pain Management Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 40. Asia-Pacific Drugs for Pain Management Market Size by Region (2019-2024) & (US$ Million)

Table 41. Asia-Pacific Drugs for Pain Management Market Size by Region (2025-2030) & (US$ Million)

Table 42. Latin America Drugs for Pain Management Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 43. Latin America Drugs for Pain Management Market Size by Country (2019-2024) & (US$ Million)

Table 44. Latin America Drugs for Pain Management Market Size by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Drugs for Pain Management Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 46. Middle East & Africa Drugs for Pain Management Market Size by Country (2019-2024) & (US$ Million)

Table 47. Middle East & Africa Drugs for Pain Management Market Size by Country (2025-2030) & (US$ Million)

Table 48. GSK Company Detail

Table 49. GSK Business Overview

Table 50. GSK Drugs for Pain Management Product

Table 51. GSK Revenue in Drugs for Pain Management Business (2019-2024) & (US$ Million)

Table 52. GSK Recent Development

Table 53. Pfizer Company Detail

Table 54. Pfizer Business Overview

Table 55. Pfizer Drugs for Pain Management Product

Table 56. Pfizer Revenue in Drugs for Pain Management Business (2019-2024) & (US$ Million)

Table 57. Pfizer Recent Development

Table 58. Grunenthal Company Detail

Table 59. Grunenthal Business Overview

Table 60. Grunenthal Drugs for Pain Management Product

Table 61. Grunenthal Revenue in Drugs for Pain Management Business (2019-2024) & (US$ Million)

Table 62. Grunenthal Recent Development

Table 63. Sanofi Company Detail

Table 64. Sanofi Business Overview

Table 65. Sanofi Drugs for Pain Management Product

Table 66. Sanofi Revenue in Drugs for Pain Management Business (2019-2024) & (US$ Million)

Table 67. Sanofi Recent Development

Table 68. Bayer Company Detail

Table 69. Bayer Business Overview

Table 70. Bayer Drugs for Pain Management Product

Table 71. Bayer Revenue in Drugs for Pain Management Business (2019-2024) & (US$ Million)

Table 72. Bayer Recent Development

Table 73. AstraZeneca Company Detail

Table 74. AstraZeneca Business Overview

Table 75. AstraZeneca Drugs for Pain Management Product

Table 76. AstraZeneca Revenue in Drugs for Pain Management Business (2019-2024) & (US$ Million)

Table 77. AstraZeneca Recent Development

Table 78. Eli Lilly Company Detail

Table 79. Eli Lilly Business Overview

Table 80. Eli Lilly Drugs for Pain Management Product

Table 81. Eli Lilly Revenue in Drugs for Pain Management Business (2019-2024) & (US$ Million)

Table 82. Eli Lilly Recent Development

Table 83. Endo Company Detail

Table 84. Endo Business Overview

Table 85. Endo Drugs for Pain Management Product

Table 86. Endo Revenue in Drugs for Pain Management Business (2019-2024) & (US$ Million)

Table 87. Endo Recent Development

Table 88. Merck Company Detail

Table 89. Merck Business Overview

Table 90. Merck Drugs for Pain Management Product

Table 91. Merck Revenue in Drugs for Pain Management Business (2019-2024) & (US$ Million)

Table 92. Merck Recent Development

Table 93. Yunnan Baiyao Company Detail

Table 94. Yunnan Baiyao Business Overview

Table 95. Yunnan Baiyao Drugs for Pain Management Product

Table 96. Yunnan Baiyao Revenue in Drugs for Pain Management Business (2019-2024) & (US$ Million)

Table 97. Yunnan Baiyao Recent Development

Table 98. Teikoku Seiyaku Company Detail

Table 99. Teikoku Seiyaku Business Overview

Table 100. Teikoku Seiyaku Drugs for Pain Management Product

Table 101. Teikoku Seiyaku Revenue in Drugs for Pain Management Business (2019-2024) & (US$ Million)

Table 102. Teikoku Seiyaku Recent Development

Table 103. Teva Company Detail

Table 104. Teva Business Overview

Table 105. Teva Drugs for Pain Management Product

Table 106. Teva Revenue in Drugs for Pain Management Business (2019-2024) & (US$ Million)

Table 107. Teva Recent Development

Table 108. J&J Company Detail

Table 109. J&J Business Overview

Table 110. J&J Drugs for Pain Management Product

Table 111. J&J Revenue in Drugs for Pain Management Business (2019-2024) & (US$ Million)

Table 112. J&J Recent Development

Table 113. Assertio Therapeutics Company Detail

Table 114. Assertio Therapeutics Business Overview

Table 115. Assertio Therapeutics Drugs for Pain Management Product

Table 116. Assertio Therapeutics Revenue in Drugs for Pain Management Business (2019-2024) & (US$ Million)

Table 117. Assertio Therapeutics Recent Development

Table 118. Allergan Company Detail

Table 119. Allergan Business Overview

Table 120. Allergan Drugs for Pain Management Product

Table 121. Allergan Revenue in Drugs for Pain Management Business (2019-2024) & (US$ Million)

Table 122. Allergan Recent Development

Table 123. Research Programs/Design for This Report

Table 124. Key Data Information from Secondary Sources

Table 125. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Drugs for Pain Management Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Drugs for Pain Management Market Share by Type: 2023 VS 2030

Figure 3. Generic Opioid Features

Figure 4. Branded Opioids Features

Figure 5. NSAIDs Features

Figure 6. Others Features

Figure 7. Global Drugs for Pain Management Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 8. Global Drugs for Pain Management Market Share by Application: 2023 VS 2030

Figure 9. Hospitals Case Studies

Figure 10. Drugstores Case Studies

Figure 11. Others Case Studies

Figure 12. Drugs for Pain Management Report Years Considered

Figure 13. Global Drugs for Pain Management Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 14. Global Drugs for Pain Management Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 15. Global Drugs for Pain Management Market Share by Region: 2023 VS 2030

Figure 16. Global Drugs for Pain Management Market Share by Players in 2023

Figure 17. Global Top Drugs for Pain Management Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drugs for Pain Management as of 2023)

Figure 18. The Top 10 and 5 Players Market Share by Drugs for Pain Management Revenue in 2023

Figure 19. North America Drugs for Pain Management Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 20. North America Drugs for Pain Management Market Share by Country (2019-2030)

Figure 21. United States Drugs for Pain Management Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Canada Drugs for Pain Management Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Europe Drugs for Pain Management Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Europe Drugs for Pain Management Market Share by Country (2019-2030)

Figure 25. Germany Drugs for Pain Management Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. France Drugs for Pain Management Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. U.K. Drugs for Pain Management Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Italy Drugs for Pain Management Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Russia Drugs for Pain Management Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Nordic Countries Drugs for Pain Management Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Asia-Pacific Drugs for Pain Management Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Asia-Pacific Drugs for Pain Management Market Share by Region (2019-2030)

Figure 33. China Drugs for Pain Management Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Japan Drugs for Pain Management Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. South Korea Drugs for Pain Management Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Southeast Asia Drugs for Pain Management Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. India Drugs for Pain Management Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Australia Drugs for Pain Management Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Latin America Drugs for Pain Management Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Latin America Drugs for Pain Management Market Share by Country (2019-2030)

Figure 41. Mexico Drugs for Pain Management Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Brazil Drugs for Pain Management Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Middle East & Africa Drugs for Pain Management Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Middle East & Africa Drugs for Pain Management Market Share by Country (2019-2030)

Figure 45. Turkey Drugs for Pain Management Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Saudi Arabia Drugs for Pain Management Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. GSK Revenue Growth Rate in Drugs for Pain Management Business (2019-2024)

Figure 48. Pfizer Revenue Growth Rate in Drugs for Pain Management Business (2019-2024)

Figure 49. Grunenthal Revenue Growth Rate in Drugs for Pain Management Business (2019-2024)

Figure 50. Sanofi Revenue Growth Rate in Drugs for Pain Management Business (2019-2024)

Figure 51. Bayer Revenue Growth Rate in Drugs for Pain Management Business (2019-2024)

Figure 52. AstraZeneca Revenue Growth Rate in Drugs for Pain Management Business (2019-2024)

Figure 53. Eli Lilly Revenue Growth Rate in Drugs for Pain Management Business (2019-2024)

Figure 54. Endo Revenue Growth Rate in Drugs for Pain Management Business (2019-2024)

Figure 55. Merck Revenue Growth Rate in Drugs for Pain Management Business (2019-2024)

Figure 56. Yunnan Baiyao Revenue Growth Rate in Drugs for Pain Management Business (2019-2024)

Figure 57. Teikoku Seiyaku Revenue Growth Rate in Drugs for Pain Management Business (2019-2024)

Figure 58. Teva Revenue Growth Rate in Drugs for Pain Management Business (2019-2024)

Figure 59. J&J Revenue Growth Rate in Drugs for Pain Management Business (2019-2024)

Figure 60. Assertio Therapeutics Revenue Growth Rate in Drugs for Pain Management Business (2019-2024)

Figure 61. Allergan Revenue Growth Rate in Drugs for Pain Management Business (2019-2024)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions